Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Vesteraalens is a Norwegian marine biotechnology company specializing in the production of high-quality Omega-3 concentrates and marine ingredients. Based in Sortland, the company leverages its proximity to the cold, clean waters of the Arctic to process fresh raw materials into oils with exceptionally low oxidation levels. Their product portfolio includes eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) concentrates used in pharmaceutical, nutraceutical, and functional food applications. Vesteraalens operates a state-of-the-art, GMP-certified production facility that ensures full traceability from the catch to the final refined product. The company is recognized for its commitment to sustainability and its ability to deliver high-purity marine lipids that meet stringent international standards. Vesteraalens serves as a key supplier and contract manufacturer for global health brands seeking premium marine-derived ingredients.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Vesteraalens.